Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS SA (SOPH), sold 3 shares at $4.71 ($14) on 2026-03-31, disclosed to the SEC on 2026-04-01.
Open-market sale of $14 SOPH by Chief Sales Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SOPH | SELL | 2026-05-20 | $150 | — | Filing → |
| SOPH | SELL | 2026-04-21 | $168 | — | Filing → |
| SOPH | SELL | 2026-04-08 | $3K | — | Filing → |